Varenicline for cannabis use disorder: A randomized controlled trial

Varenicline with medical management resulted in decreased cannabis use among men with cannabis use disorder seeking treatment, but not women (no effect was observed on the overall sample of treatment-seeking individuals with cannabis use disorder).

Authors

Institutions

Publication Details

Journal
Addiction
Published
2026-01-14
DOI
https://doi.org/10.1111/add.70296
Primary Topic
Cannabis and Cannabinoid Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Varenicline for cannabis use disorder: A randomized controlled trial

Aimee L. McRae‐Clark, Bryan K. Tolliver, Amanda Wagner, Elizabeth Chapman et al.
Addiction
Cannabis and Cannabinoid Research
article

Varenicline for cannabis use disorder: A randomized controlled trial

Aimee L. McRae‐Clark, Bryan K. Tolliver, Amanda Wagner, Elizabeth Chapman, Nathaniel L. Baker, Kevin M. Gray, Brian J. Sherman, Alonzo Steplight, Jessica Burt
article en

Abstract

Varenicline with medical management resulted in decreased cannabis use among men with cannabis use disorder seeking treatment, but not women (no effect was observed on the overall sample of treatment-seeking individuals with cannabis use disorder).

Addiction
Medical University of South Carolina (US), Ralph H. Johnson VA Medical Center (US)
National Institutes of Health
Good health and well-being
Openalex Percentile: Top 85%
Cannabis and Cannabinoid Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.